NCT00494312 Safety Study of Pioglitazone Compared To Glyburide on Liver Function Status COMPLETED Phase PHASE4
NCT00492232 Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia Status COMPLETED Phase PHASE4
NCT00492011 Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers Status COMPLETED Phase PHASE4
NCT00487994 Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia Status COMPLETED Phase PHASE3
NCT00479986 Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease Status COMPLETED Phase PHASE4
NCT00471094 Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis Status COMPLETED Phase PHASE2
NCT00449813 The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) Status TERMINATED Phase PHASE4
NCT00449553 Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. Status COMPLETED Phase N/A
NCT00432276 Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00430248 Efficacy and Safety of Oral Febuxostat in Participants With Gout Status COMPLETED Phase PHASE3
NCT00414102 Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia. Status COMPLETED Phase PHASE4
NCT00395512 Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00380250 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Status COMPLETED Phase PHASE3
NCT00377598 Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia Status COMPLETED Phase PHASE2/PHASE3
NCT00376181 Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT00375388 The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial Status COMPLETED Phase PHASE3